China Pharma Holdings Gross Margin 2010-2023 | CPHI
Current and historical gross margin for China Pharma Holdings (CPHI) over the last 10 years. The current gross profit margin for China Pharma Holdings as of December 31, 2023 is %.
| China Pharma Holdings Gross Margin Historical Data |
| Date |
TTM Revenue |
TTM Gross Profit |
Gross Margin |
| 2023-12-31 |
$0.01B |
0 |
0.00% |
| 2023-09-30 |
$0.01B |
0 |
0.00% |
| 2023-06-30 |
$0.01B |
0 |
0.00% |
| 2023-03-31 |
$0.01B |
0 |
0.00% |
| 2022-12-31 |
$0.01B |
0 |
0.00% |
| 2022-09-30 |
$0.01B |
0 |
0.00% |
| 2022-06-30 |
$0.01B |
0 |
0.00% |
| 2022-03-31 |
$0.01B |
0 |
0.00% |
| 2021-12-31 |
$0.01B |
0 |
0.00% |
| 2021-09-30 |
$0.01B |
$0.00B |
11.11% |
| 2021-06-30 |
$0.01B |
$0.00B |
11.11% |
| 2021-03-31 |
$0.01B |
$0.00B |
18.18% |
| 2020-12-31 |
$0.01B |
$0.00B |
18.18% |
| 2020-09-30 |
$0.01B |
$0.00B |
9.09% |
| 2020-06-30 |
$0.01B |
$0.00B |
9.09% |
| 2020-03-31 |
$0.01B |
0 |
0.00% |
| 2019-12-31 |
$0.01B |
$0.00B |
9.09% |
| 2019-09-30 |
$0.01B |
$0.00B |
9.09% |
| 2019-06-30 |
$0.01B |
$0.00B |
18.18% |
| 2019-03-31 |
$0.01B |
$0.00B |
27.27% |
| 2018-12-31 |
$0.01B |
$0.00B |
25.00% |
| 2018-09-30 |
$0.01B |
$0.00B |
30.77% |
| 2018-06-30 |
$0.01B |
$0.00B |
21.43% |
| 2018-03-31 |
$0.01B |
$0.00B |
21.43% |
| 2017-12-31 |
$0.01B |
$0.00B |
23.08% |
| 2017-09-30 |
$0.01B |
$0.00B |
28.57% |
| 2017-06-30 |
$0.01B |
$0.00B |
28.57% |
| 2017-03-31 |
$0.02B |
$0.00B |
20.00% |
| 2016-12-31 |
$0.02B |
$0.00B |
18.75% |
| 2016-09-30 |
$0.02B |
$0.00B |
6.25% |
| 2016-06-30 |
$0.02B |
$0.00B |
5.88% |
| 2016-03-31 |
$0.02B |
$0.00B |
5.26% |
| 2015-12-31 |
$0.02B |
$0.00B |
4.76% |
| 2015-09-30 |
$0.02B |
$-0.00B |
-15.79% |
| 2015-06-30 |
$0.02B |
$-0.00B |
-4.76% |
| 2015-03-31 |
$0.02B |
$0.00B |
4.76% |
| 2014-12-31 |
$0.02B |
$0.00B |
13.64% |
| 2014-09-30 |
$0.03B |
$0.00B |
14.81% |
| 2014-06-30 |
$0.03B |
$0.00B |
13.79% |
| 2014-03-31 |
$0.03B |
$0.00B |
12.90% |
| 2013-12-31 |
$0.03B |
$-0.00B |
-3.13% |
| 2013-09-30 |
$0.04B |
$0.00B |
8.33% |
| 2013-06-30 |
$0.04B |
$0.00B |
10.00% |
| 2013-03-31 |
$0.05B |
$0.01B |
12.77% |
| 2012-12-31 |
$0.06B |
$0.01B |
23.64% |
| 2012-09-30 |
$0.07B |
$0.02B |
29.23% |
| 2012-06-30 |
$0.07B |
$0.02B |
32.43% |
| 2012-03-31 |
$0.08B |
$0.03B |
34.18% |
| 2011-12-31 |
$0.08B |
$0.03B |
35.80% |
| 2011-09-30 |
$0.08B |
$0.03B |
37.35% |
| 2011-06-30 |
$0.08B |
$0.03B |
38.27% |
| 2011-03-31 |
$0.08B |
$0.03B |
39.74% |
| 2010-12-31 |
$0.08B |
$0.03B |
40.00% |
| 2010-09-30 |
$0.07B |
$0.03B |
39.44% |
| 2010-06-30 |
$0.07B |
$0.03B |
39.71% |
| 2010-03-31 |
$0.07B |
$0.03B |
40.00% |
| 2009-12-31 |
$0.06B |
$0.03B |
41.27% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.005B |
$0.007B |
|
CHINA PHARMA HOLDINGS, Inc. develops, manufactures, and markets generic and brand bio-pharmaceutical products in China that treat a wide range of conditions, including infections, hepatitis, cardiovascular and CNS diseases, and other prevailing diseases. Helpson Bio-pharmaceutical Co., Ltd. (Helpson), a specialty pharmaceutical company headquartered in Haikou City, Hainan province in China, is a wholly owned subsidiary of China Pharma Holdings.
|
